Any wrong or incomplete data? Any missing, misplaced, unlicensed picture? Please report any abuse, inaccuracy or lack of information to info@ticinoscienza.ch

1) A Systematic Review of the Efficacy and Toxicity of Brachytherapy Boost Combined with External Beam Radiotherapy for Nonmetastatic Prostate Cancer
European Urology Oncology, 26 dicembre 2023

2) Re: Timothée Olivier, Kerrington Powell, Vinay Prasad. Lutetium-177-PSMA-617 in Metastatic Castration-resistant Prostate Cancer: Limitations of the VISION Trial. Eur Urol. 2023;84:4-6
European Urology, ottobre 2023

3) Proteomics of immune cells from liver tumors reveals immunotherapy targets
Cell Genomics, 30 maggio 2023

4) Abiraterone acetate plus prednisolone with or without enzalutamide for patients with metastatic prostate cancer starting androgen deprivation therapy: final results ...
The Lancet Oncology, marzo 2023

5) Impact of Epithelial Histological Types, Subtypes, and Growth Patterns on Oncological Outcomes for Patients with Nonmetastatic Prostate Cancer Treated with Curative Intent: A Systematic Review
European Urology, 27 aprile 2023

6) Visceral Metastasis Predicts Response to New Hormonal Agents in Metastatic Castration-Sensitive Prostate Cancer
The Oncologist, 21 aprile 2023

7) Next Generation Radiotheranostics Promoting Precision Medicine
Annals of Oncology, 14 marzo 2023

8) Updated treatment recommendations for prostate cancer from the ESMO Clinical Practice Guideline considering treatment intensification and use of novel systemic agents
Annals of Oncology, 14 marzo 2023

9) Management of patients with advanced prostate cancer-metastatic and/or castration-resistant prostate cancer: report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022
European Journal of Cancer, 3 marzo 2023

10) Apolipoprotein E induces pathogenic senescent-like myeloid cells in prostate cancer
Cancer Cell, 22 febbraio 2023

11) Management of Patients with Advanced Prostate Cancer. Part I: Intermediate-/High-risk and Locally Advanced Disease, Biochemical Relapse, and Side Effects of Hormonal Treatment: Report of the Advanced Prostate Cancer Consensus Conference 2022
European Urology, 6 dicembre 2022

12) Corrigendum to "What Experts Think About Prostate Cancer Management During the COVID-19 Pandemic: Report from the Advanced Prostate Cancer Consensus Conference 2021" [Eur Urol 82(1):6-11]
European Urology, luglio 2022

13) What Experts Think About Prostate Cancer Management During the COVID-19 Pandemic: Report from the Advanced Prostate Cancer Consensus Conference 2021
European Urology, luglio 2022

14) Clinical trials for metastatic castrate-resistant prostate cancer-who is looking after the control patients? Questions for the future
Annals of Oncology, giugno 2022

15) P1245 Polymorphic Variants of HSD3B1 Gene Confer Different Outcome in Specific Subgroups of Patients Infected With SARS-CoV-2
Frontiers in Medicine, 7 luglio 2022

16) Prostate Cancer and Sleep Disorders: A Systematic Review
Cancers, 31 marzo 2022

17) A European Oncology Leader Looks at PSMA: A Conversation Between Silke Gillessen, Johannes Czernin, and Ken Herrmann
The Journal of Nuclear Medicine, febbraio 2022

18) Immune Checkpoint Inhibitors in Advanced Prostate Cancer: Current Data and Future Perspectives
Cancers, 28 febbraio 2022

19) Testicular seminoma and non-seminoma: ESMO-EURACAN Clinical Practice Guideline for diagnosis, treatment and follow-up
Annals of Oncology, 17 gennaio 2022

20) Establishing metastatic prostate cancer quality indicators using a modified Delphi approach
Clinical Genitourinary Cancer, 7 gennaio 2022

21) Commensal bacteria promote endocrine resistance in prostate cancer through androgen biosynthesis
Science, 8 ottobre 2021

22) In-depth analysis of the 2019 Advanced Prostate Cancer Consensus Conference (APCCC) - The importance of representation of medical specialty and geographic regions
European Urology Open Science, aprile 2021

23) Combined Longitudinal Clinical and Autopsy Phenomic Assessment in Lethal Metastatic Prostate Cancer: Recommendations for Advancing Precision Medicine
European Urology Open Science, 2 luglio 2021

24) Evaluation of Oncological Outcomes and Data Quality in Studies Assessing Nerve-sparing Versus Non-Nerve-sparing Radical Prostatectomy in Nonmetastatic Prostate Cancer: A Systematic Review
European Urology Focus, 16 giugno 2021

25) Metastatic Prostate Cancer: In Search of More Granularity
Journal of Clinical Oncology, 14 maggio 2021

26) Patient- and Tumour-related Prognostic Factors for Urinary Incontinence After Radical Prostatectomy for Nonmetastatic Prostate Cancer: A Systematic Review and Meta-analysis
European Urology Focus, 6 maggio 2021

27) A Systematic Review of the Impact of Surgeon and Hospital Caseload Volume on Oncological and Nononcological Outcomes After Radical Prostatectomy for Nonmetastatic Prostate Cancer
European Urology, 4 maggio 2021

28) Consensus on the Treatment and Follow-Up for Metastatic Castration-Resistant Prostate Cancer: A Report From the First Global Prostate Cancer Consensus Conference for Developing Countries (PCCCDC)
JCO Global Oncology, aprile 2021

29) Consensus on the Screening, Staging, Treatment, and Surveillance of Localized, Recurrent, and Metastatic Prostate Cancer: The First Global Prostate Cancer Consensus Conference for Developing Countries
JCO Global Oncology, aprile 2021

30) Consensus for Treatment of Metastatic Castration-Sensitive Prostate Cancer: Report From the First Global Prostate Cancer Consensus Conference for Developing Countries (PCCCDC)
JCO Global Oncology, aprile 2021

31) Predicting Outcomes in Men With Metastatic Nonseminomatous Germ Cell Tumors (NSGCT): Results From the IGCCCG Update Consortium
Journal of Clinical Oncology, 6 aprile 2021

32) Survival and New Prognosticators in Metastatic Seminoma: Results From the IGCCCG-Update Consortium
Journal of Clinical Oncology, 17 marzo 2021

33) Association of Bone Metastatic Burden With Survival Benefit From Prostate Radiotherapy in Patients With Newly Diagnosed Metastatic Prostate Cancer: A Secondary Analysis of a Randomized Clinical Trial
JAMA Oncology, 18 febbraio 2021

34) Management of Persistently Elevated Prostate-specific Antigen After Radical Prostatectomy: A Systematic Review of the Literature
European Urology Oncology, 8 febbraio 2021

35) Prostate cancer
Nature Reviews Disease Primers, 4 febbraio 2021

36) A Systematic Review of Focal Ablative Therapy for Clinically Localised Prostate Cancer in Comparison with Standard Management Options: Limitations of the Available Evidence and Recommendations for Clinical Practice and Further Research
European Urology Oncology, 7 gennaio 2021

37) Influence of abiraterone and enzalutamide on body composition in patients with metastatic castration resistant prostate cancer
Cancer Treatment and Research Communications, 1 dicembre 2020

38) EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer-2020 Update. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent
European Urology, 7 novembre 2020

39) Activity of Platinum-Based Chemotherapy in Patients With Advanced Prostate Cancer With and Without DNA Repair Gene Aberrations
JAMA Network Open, 28 ottobre 2020

40) EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer. Part II-2020 Update: Treatment of Relapsing and Metastatic Prostate Cancer
European Urology, https://www.sciencedirect.com/science/article/abs/pii/S0302283820307739?via%3Dihub

41) Precision Oncology for Metastatic Prostate Cancer: Translation into Practice
European Urology, https://www.sciencedirect.com/science/article/abs/pii/S0302283820306382?via%3Dihub

42) When What You See Is Not Always What You Get: Raising the Bar of Evidence for New Diagnostic Imaging Modalities
European Urology, https://www.europeanurology.com/article/S0302-2838(20)30601-1/fulltext

43) Prostate Cancer: ESMO Clinical Practice Guidelines for Diagnosis, Treatment and Follow-Up
Annals of Oncology, https://www.annalsofoncology.org/article/S0923-7534(20)39898-7/pdf

44) Immune-checkpoint Inhibitors and Metastatic Prostate Cancer Therapy: Learning by Making Mistakes
Cancer Treatment Reviews, https://www.cancertreatmentreviews.com/article/S0305-7372(20)30095-5/pdf

45) International prognostic score for asymptomatic early-stage chronic lymphocytic leukemia
Blood, 21 maggio 2020

46) Risks from Deferring Treatment for Genitourinary Cancers: A Collaborative Review to Aid Triage and Management During the COVID-19 Pandemic.
European Urology, https://www.europeanurology.com/article/S0302-2838(20)30331-6/pdf

47) Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019.
European Urology, https://www.europeanurology.com/article/S0302-2838(20)30048-8/fulltext
Silke Gillessen Sommer
is Head of Research Programs [Rif. 20700]
at Istituto Oncologico Svizzera Italiana (IOSI) (Rif. IOSI)
Via Gallino 12 (ex Via Ospedale) 6500 Bellinzona